News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
468,121 Results
Type
Article (17280)
Company Profile (130)
Press Release (450711)
Section
Business (149420)
Career Advice (826)
Deals (25508)
Drug Delivery (31)
Drug Development (41930)
Employer Resources (72)
FDA (10331)
Job Trends (9478)
News (229634)
Policy (16583)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1400)
Adcomms (3)
Allergies (39)
Alliances (39493)
ALS (30)
Alzheimer's disease (603)
Antibody-drug conjugate (ADC) (57)
Approvals (10344)
Artificial intelligence (215)
Autoimmune disease (2)
Automation (11)
Bankruptcy (186)
Best Places to Work (7697)
BIOSECURE Act (6)
Biosimilars (18)
Biotechnology (101)
Bladder cancer (26)
Brain cancer (15)
Breast cancer (123)
Cancer (1029)
Cardiovascular disease (59)
Career advice (721)
Career pathing (9)
CAR-T (92)
Cell therapy (271)
Cervical cancer (6)
Clinical research (33593)
Collaboration (561)
Compensation (193)
Complete response letters (4)
COVID-19 (1233)
CRISPR (32)
C-suite (138)
Cystic fibrosis (59)
Data (1029)
Decentralized trials (1)
Denatured (18)
Depression (17)
Diabetes (99)
Diagnostics (5325)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (19)
Drug discovery (74)
Drug pricing (17)
Drug shortages (4)
Duchenne muscular dystrophy (16)
Earnings (59192)
Editorial (3)
Employer branding (11)
Employer resources (65)
Events (72439)
Executive appointments (452)
FDA (10915)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (466)
Gene editing (75)
Generative AI (23)
Gene therapy (163)
GLP-1 (264)
Government (1462)
Grass and pollen (1)
Guidances (26)
Healthcare (12225)
Huntington's disease (6)
IgA nephropathy (7)
Immunology and inflammation (30)
Indications (11)
Infectious disease (1302)
Inflammatory bowel disease (70)
Inflation Reduction Act (3)
Influenza (31)
Intellectual property (50)
Interviews (98)
IPO (11903)
IRA (8)
Job creations (2099)
Job search strategy (647)
Kidney cancer (6)
Labor market (9)
Layoffs (184)
Leadership (6)
Legal (4000)
Liver cancer (37)
Lung cancer (124)
Lymphoma (64)
Machine learning (2)
Management (24)
Manufacturing (161)
MASH (28)
Medical device (12105)
Medtech (12110)
Mergers & acquisitions (13933)
Metabolic disorders (240)
Multiple sclerosis (24)
NASH (7)
Neurodegenerative disease (25)
Neuropsychiatric disorders (3)
Neuroscience (806)
NextGen: Class of 2025 (4301)
Non-profit (1953)
Northern California (1445)
Now hiring (9)
Obesity (108)
Opinion (98)
Ovarian cancer (41)
Pain (44)
Pancreatic cancer (37)
Parkinson's disease (62)
Partnered (10)
Patents (121)
Patient recruitment (50)
Peanut (25)
People (42755)
Pharmaceutical (22)
Pharmacy benefit managers (1)
Phase I (11453)
Phase II (14901)
Phase III (10482)
Pipeline (582)
Podcasts (36)
Policy (26)
Postmarket research (990)
Preclinical (4917)
Press Release (72)
Prostate cancer (47)
Psychedelics (7)
Radiopharmaceuticals (192)
Rare diseases (167)
Real estate (4147)
Recruiting (26)
Regulatory (11943)
Reports (20)
Research institute (1385)
Resumes & cover letters (124)
Rett syndrome (2)
RNA editing (1)
RSV (19)
Schizophrenia (21)
Series A (84)
Series B (52)
Service/supplier (7)
Sickle cell disease (21)
Southern California (1294)
Special edition (2)
Sponsored (14)
Startups (2810)
State (2)
Stomach cancer (2)
Supply chain (26)
The Weekly (17)
United States (12943)
Vaccines (302)
Venture capitalists (20)
Webinars (10)
Weight loss (46)
Women's health (16)
Worklife (2)
Date
Today (112)
Last 7 days (514)
Last 30 days (1945)
Last 365 days (23101)
2025 (3823)
2024 (23912)
2023 (28220)
2022 (37974)
2021 (40235)
2020 (38228)
2019 (31602)
2018 (23944)
2017 (23274)
2016 (22000)
2015 (26342)
2014 (19973)
2013 (16604)
2012 (17925)
2011 (18541)
2010 (17313)
Location
Africa (424)
Alabama (44)
Alaska (7)
Arizona (130)
Arkansas (10)
Asia (28174)
Australia (4766)
California (3368)
Canada (1244)
China (223)
Colorado (171)
Connecticut (167)
Delaware (47)
Europe (59989)
Florida (496)
Georgia (126)
Idaho (43)
Illinois (299)
India (11)
Indiana (169)
Iowa (4)
Japan (101)
Kansas (84)
Kentucky (13)
Louisiana (6)
Maine (55)
Maryland (470)
Massachusetts (2469)
Michigan (187)
Minnesota (278)
Mississippi (2)
Missouri (61)
Montana (28)
Nebraska (20)
Nevada (36)
New Hampshire (64)
New Jersey (956)
New Mexico (18)
New York (922)
North Carolina (622)
North Dakota (7)
Northern California (1445)
Ohio (119)
Oklahoma (11)
Oregon (19)
Pennsylvania (659)
Puerto Rico (4)
Rhode Island (20)
South America (657)
South Carolina (12)
South Dakota (1)
Southern California (1294)
Tennessee (61)
Texas (490)
Utah (102)
Virginia (66)
Washington D.C. (16)
Washington State (346)
West Virginia (3)
Wisconsin (37)
468,121 Results for "curexo technology corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
CUREXO INC.'S ROBOTIC GAIT TRAINING SYSTEM, MORNING WALK S200, INSTALLED IN FIRST US INPATIENT REHABILITATION FACILITY
In continuing its strategic partnership with Curexo, Inc. announced last year, Harmonic Bionics has completed the first installation of Curexo’s Morning Walk S200 at an inpatient rehabilitation facility in the US.
March 29, 2023
·
2 min read
Press Releases
Daxor Corporation Expands Blood Volume Analysis Technology to Major New Jersey Hospitals
February 27, 2025
·
3 min read
Biotech Beach
THINK Surgical and Curexo Announce Entry Into Development and Distribution Agreement
THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, announced its entry into a development and distribution agreement with Curexo, Inc., a medical robotics specialist company based in South Korea.
August 1, 2022
·
4 min read
Deals
NanoString Technologies to Be Acquired by Bruker Corporation
NanoString Technologies, Inc. (“NanoString” or “the Company”) today announced that substantially all of its assets will be acquired by Bruker Corporation (“Bruker”), a global life science analytical instrument company, for approximately $392.6 million in cash consideration, plus the assumption of certain liabilities.
April 17, 2024
·
6 min read
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
Business
GT Medical Technologies, Inc. and Theragenics Corporation Forge Distribution Partnership for Cesium-131
GT Medical Technologies, Inc. today announced it has entered into a strategic distribution partnership with Theragenics Corporation® (Theragenics), a global leader in minimally invasive brachytherapy.
May 1, 2024
·
4 min read
BioForest
Simulab Corporation Announces New Technology in Medical Simulation With SimuSkin(TM)
Simulab Corporation proudly unveils its latest technology - SimuSkin.
January 18, 2024
·
2 min read
Press Releases
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
March 4, 2025
·
13 min read
Press Releases
Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq’s Novel Surface Treatment Technology
February 19, 2025
·
3 min read
Business
Sensient Technologies Corporation Reports Results for the Quarter Ended March 31, 2024 and Raises Full Year Guidance
Sensient Technologies Corporation, a leading provider of flavors and colors for the food, pharmaceutical, and personal care markets, reported financial results for the first quarter ended March 31, 2024.
April 26, 2024
·
16 min read
1 of 46,813
Next
